Cart
sales@molnova.com
BIIB 722 Mesylate
CAS No. 261505-81-1
BIIB 722 Mesylate( —— )
Catalog No. M37367 CAS No. 261505-81-1
BIIB 722 Mesylate is a selective sodium-hydrogen exchange inhibitor with cardioprotective properties and can be used to study myocardial ischemia and myocardial infarction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | Get Quote |
|
| 5MG | 459 | Get Quote |
|
| 10MG | 657 | Get Quote |
|
| 25MG | 994 | Get Quote |
|
| 50MG | 1371 | Get Quote |
|
| 100MG | 1773 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBIIB 722 Mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionBIIB 722 Mesylate is a selective sodium-hydrogen exchange inhibitor with cardioprotective properties and can be used to study myocardial ischemia and myocardial infarction.
-
DescriptionBIIB 722 Mesylate is a selective sodium-hydrogen exchange inhibitor with cardioprotective properties and can be used to study myocardial ischemia and myocardial infarction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number261505-81-1
-
Formula Weight504.483
-
Molecular FormulaC19H23F3N6O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC(=N)N)C1=CC=C(C(=C1)C(F)(F)F)N2CCN(C(=O)C3=CC=CN3)CC2.O=S(=O)(O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PF-05089771 free bas...
PF-05089771 free base is a potent, subtype selective Nav1.7 inhibitor with IC50 of 11 nM.
-
Carbamazepine
Carbamazepine, a?sodium channel?blocker, is an anticonvulsant drug.
-
Tolperisone hydrochl...
Tolperisone hydrochloride?is a centrally acting muscle relaxant, is indicated for use in the treatment of pathologically increased tone of the cross-striated muscle caused by neurological diseases.
